Presentation Title Presenter(s) Centers for Disease Control and Prevention AIDS 2012 - Turning the Tide Together.

Slides:



Advertisements
Similar presentations
Sexually Transmitted Disease Surveillance 2012 Division of STD Prevention 2012 Data.
Advertisements

Preventing HIV Drug Resistance with Programmatic Action Michael R. Jordan MD MPH.
Dr. Koku Kazaura, Prevention Team Lead, CDC - Tanzania
Elizabeth Medlin, MPH Global Water, Sanitation, and Hygiene Team Environmental Health Services Branch U.S. Centers for Disease Control and Prevention Rick.
Rabies Surveillance in the United States During 2012 Division of High-Consequence Pathogens and Pathology Poxvirus and Rabies Branch March 2014 National.
STDs in Adolescents and Young Adults Sexually Transmitted Disease Surveillance 2009 Division of STD Prevention.
Brandi Cooke Student Intern 3 rd National Summit on Preconception Health and Health Care June 12-14, 2011 Factors Affecting the Willingness of Counselors.
The Implementation of the WHO Asia Pacific Treatment Metrics Dr. YU, Dongbao WHO Regional Office for the Western Pacific 20 July, 2014 Antiretroviral Treatment.
11 Lynda A. Anderson, PhD Director, Healthy Aging Program Division of Population Health National Center for Chronic Disease Prevention and Health Promotion.
Endeavors in Transportation Health Impact Assessment LCDR Joseph Ralph, MPH, CHES Healthy Community Design Initiative June 2015 National Center for Environmental.
Eliminating Lymphatic Filariasis in the Americas A Winnable Battle Center for Global Health Division of Parasitic Diseases and Malaria.
Database Structure Basics National Center for Immunization & Respiratory Diseases Influenza Division Pam Kennedy Analyst, McKing Consulting Regional Training.
Creating an AIDS-Free Generation The beginning of the end of AIDS Center for Strategic & International Studies Washington, DC March 22, 2012 Thomas R.
Assessment of Program Evaluation Activities in Tuberculosis Control Programs — United States, 2009–2010 Silvia M. Trigoso, MPH Fellow, Public Health Prevention.
Kevin Caspary, MPH Oak Ridge Institute for Science and Education Community Reception Center Operations for Radiation Emergency Response: Tools for Training.
Meredith Carr, JD J. Stan Lehman, MPH David W. Purcell, JD, PhD Division of HIV/AIDS Prevention Centers for Disease Control and Prevention July 25, 2012.
Kirk Smith MN, Carina Blackmore FL, John Dunn TN, Alicia Cronquist CO, Bill Keene OR Dale Morse & Don Sharp CDC CSTE Annual Meeting June 12, 2013 National.
Identifying Problem Sources at Data Entry and Collection National Center for Immunization & Respiratory Diseases Influenza Division Nishan Ahmed Regional.
Nedra Garrett Director, Division of Informatics Practice, Policy, and Coordination (DIPPC) PHIN Partner Call April 20, 2011 Public Health Information Network.
Center for Global Health Division of Global HIV/AIDS John Pitman Division of Global HIV/AIDS, Center for Global Health, CDC.
Assessing & Improving Quality of Care Newly Developed Quality of Care Tools President’s Emergency Plan for AIDS Relief Track 1.0 ART Program Meeting Seema.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention HIV testing among transgender persons funded by the.
James W. Buehler, MD Director, Public Health Surveillance Program Office, OSELS, CDC CSTE Annual Conference June 13, 2011 Pittsburgh, PA Public Health.
IAWG GESC February 12, 2014 NYC, NY Retrospective Analysis of Reproductive Health and HIV/AIDS Indicators in United Nations High Commissioner for Refugees.
Sexually Transmitted Disease Surveillance 2012 Division of STD Prevention.
Elliot Raizes, MD HIV Care and Treatment Branch AIDS 2012: WHO Satellite Symposium HIV Drug Resistance Surveillance and Control: A Global Concern July.
Public Health Birth Defects Surveillance
Office of Public Health Preparedness and Response Division of Strategic National Stockpile Ben Erickson Public Health Analyst Inventory Management Tracking,
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
Preliminary Considerations for Analyzing Physical Education Curricula Lesson 3 PECAT Physical Education Curriculum Analysis Tool National Center for Chronic.
Center for Surveillance, Epidemiology, and Laboratory Services Division of Health Informatics and Surveillance Demonstration and Workshop Highlighting.
Epidemiology of Tuberculosis in Correctional Facilities, United States, Surveillance, Epidemiology and Outbreak Investigations Branch Division.
Elizabeth Medlin, M.PH. Global Water, Sanitation, and Hygiene Team Environmental Health Services Branch U.S. Centers for Disease Control and Prevention.
Infection Prevention in US Outpatient Oncology Settings Alice Guh, MD. MPH National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare.
STDs in Persons Entering Corrections Facilities Sexually Transmitted Disease Surveillance 2009 Division of STD Prevention.
Poxvirus and Rabies Branch November 2011 Rabies Surveillance in the United States During 2010 Division of High-Consequence Pathogens and Pathology National.
Sexually Transmitted Disease Surveillance 2012 Division of STD Prevention.
STDs in Women and Infants Sexually Transmitted Disease Surveillance 2009 Division of STD Prevention.
Other Sexually Transmitted Diseases Sexually Transmitted Disease Surveillance 2009 Division of STD Prevention.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention.
* Centers for Disease Control and Prevention. Health Education Curriculum Analysis Tool. Atlanta, GA: U.S. Department of Health and Human Services; 2011.
1 Uses of Data from the WHO HIV Drug Resistance Strategy: 1. Monitoring of HIVDR emerging in treated groups in sentinel ART clinics HIV Drug Resistance.
Scott Van Heest IT Specialist, Data Analysis and Support Team, NPCR, CDC Denise Farmer CDC/NPCR Contractor Division of Cancer Prevention and Control National.
138 th American Public Health Association Annual Meeting Denver, Colorado November 8, 2010 Determinants of HIV Testing Among High School Students with.
National Center for Emerging and Zoonotic Infectious Diseases Division of High-Consequence Pathogens and Pathology Rabies Surveillance in the United States.
Jean B. Patel, PhD, D(ABMM) Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Disease Centers for Disease Control.
HIV Drug Resistance Surveillance Satellite Session: HIV Drug Resistance Surveillance and Control: a Global Concern Silvia Bertagnolio, MD WHO,
#AIDS2016 ASSESSMENT OF THE WORLD HEALTH ORGANIZATION EARLY WARNING INDICATORS OF HIV DRUG RESISTANCE IN NAMIBIA FOR PUBLIC HEALTH ACTION,
PRESENTED AT THE 9TH IAS CONFERENCE ON HIV SCIENCE - PARIS, FRANCE
Implementation of routine HIV viral load monitoring A multisite cascade analysis Munyaradzi Dhodho1, Marthe Frieden1, Amir Shroufi2, Esther Wanjiru3, Sarah.
Differentiated Monitoring & Evaluation
Implementation of routine HIV viral load monitoring A multisite cascade analysis Munyaradzi Dhodho1, Marthe Frieden1, Amir Shroufi2, Esther Wanjiru3, Sarah.
Jepkoech Kottutt1, Emilia D. Rivadeneira2, Susan Hrapcak2
Centre for International Health, University of Bergen, Norway
Our Strategies for Viral Load Suppression
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Summary Sheet Figures and Maps
Update on global progress in ART
Presentation transcript:

Presentation Title Presenter(s) Centers for Disease Control and Prevention AIDS Turning the Tide Together

PEPFAR World Health Organization (WHO) Global HIV Drug Resistance (HIVDR) Surveillance In 2006, WHO established global HIV drug resistance surveillance using early warning indicators (EWIs) Eight EWIs were used to monitor factors associated with the emergence of HIVDR Countries conduct EWI surveys and report results annually to WHO

PEPFAR Methods: Overview For this analysis, we analyzed multi-country data reported to WHO in the period Countries selected a representative sample of clinics. Different EWIs were surveyed in different clinics, depending on the availability of data. The total number of clinics meeting the target in countries and regions in each year was summed and presented as a proportion of total clinics surveyed. We selected three EWIs thought to be closely associated with HIVDR.

PEPFAR Methods: Early Warning Indicators EWI-4 monitors antiretroviral drug (ARV) pick-ups on- time. –Target: > 90% of patients picking up ARVs on- time. –This EWI was reported by 25 countries. EWI-6 monitors ARV drug supply continuity and whether stock-outs occur in clinic pharmacies. –Target: 100% of clinic pharmacies with no stock- outs. –This EWI was reported by 32 countries. EWI-8 monitors HIV RNA (virologic) suppression. –Target: > 70% of patients with viral load < 1000 copies/ml at one year ml at one year after starting ARVs. –This EWI was reported by 6 countries.

PEPFAR EWI 4: Percentage of Clinics with On-Time ARV Pick-Ups, by Region and Year Target: > 90% of patients picking up ARVs on-time

PEPFAR EWI 6: Percentage of Clinics with ARV Supply Continuity, by Region and Year Target: 100% of clinic pharmacies with no ARV stock-outs

PEPFAR EWI 8: Percentage of Clinics with Viral Load (VL) Suppression, by Region and Year Target: > 70% of patients with VL suppressed one year post-ARV start

PEPFAR Limitations Many EWI surveys were conducted while patient-level information systems were in development The EWI global surveillance system is young, and still continues to be refined Number of countries reporting on specific EWI varies by year Sample of clinics may vary by country by year May not be same clinics year-to-year in each country

PEPFAR Actions Taken by Countries Following EWI Results Namibia –Migrant workers were seen to be at risk of treatment interruptions –MOHSS has planned an intensification of defaulter tracking systems and improvements in its electronic record system. Malawi –MOH revised electronic medical & pharmacy records to enable abstraction of EWI 4 (on-time ARV pick-ups) China –EWI assessment prompted upgrades to an Internet-based database to routinely monitor EWI at all ART clinics –Results about on-time ARV pick-ups motivated strategies to address programmatic weaknesses

PEPFAR Conclusions Countries across the world are monitoring early warning indicators associated with the emergence of HIVDR EWI results identify “on-time ARV pick-up” as a major challenge for clinics and patients. Methods to improve on-time ARV pick-ups and ARV supply chains should be prioritized by national ARV programs and individual clinics distributing ARVs. National programs have used results to adjust clinic-level information systems and clinic procedures, including adherence counseling and patient-tracking.

PEPFAR Acknowledgements Drs. Anindya De, Drew Baughman, and Yang Liu of Division of Global HIV/AIDS, CDC performed the SAS analyses. Grants from the Bill and Melinda Gates Foundation and from PEPFAR supported EWI surveys in many countries. We acknowledge Ministry of Health staff and local CDC staff in many countries who made these analyses possible.

PEPFAR For more information please contact Centers for Disease Control and Prevention 1600 Clifton Road NE, Atlanta, GA Telephone: CDC-INFO ( )/TTY: Web: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.